Benchmark Raises PT On Bio-Reference Labs To $29

May 27, 2011 6:22 AM | 8 seconds read | Make a Comment

The Benchmark Company has raised the price target on Bio-Reference Labs

BRLI

from $25 to $29 and maintains its Buy rating.

Posted In: Price Target Analyst Ratings Benchmark Bio-Reference Laboratories Health Care Health Care Services

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.